In general, AD-relevant mutations drive APP processing towards the amyloidogenic pathway leading to the accumulation of Aβ peptides and oligomers, an early step in neuronal dysfunction, although the exact mechanisms by which APP misprocessing leads to AD are not fully understood. This evidence concerns the gene APP and Alzheimer disease.